| Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. |
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. |
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. |
Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 |
Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 |
Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 |
2019/06 |
有 |
|
|
公開 |
| Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T |
Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T |
Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T |
Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. |
Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. |
Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. |
Modern rheumatology, 1-21 |
Modern rheumatology, 1-21 |
Modern rheumatology, 1-21 |
2019/05 |
有 |
|
|
公開 |
| Yoshifuji H |
Yoshifuji H |
Yoshifuji H |
Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. |
Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. |
Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. |
Modern rheumatology, 29, 2, 287-293 |
Modern rheumatology, 29, 2, 287-293 |
Modern rheumatology, 29, 2, 287-293 |
2019/03 |
有 |
|
|
公開 |
| Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T |
Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T |
Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T |
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. |
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. |
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. |
Modern rheumatology, 1-5 |
Modern rheumatology, 1-5 |
Modern rheumatology, 1-5 |
2019/02 |
有 |
|
|
公開 |
| Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F |
Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. |
Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. |
Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. |
Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 |
Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 |
Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 |
2018/12 |
有 |
|
|
公開 |
| Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M |
Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M |
Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M |
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. |
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. |
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. |
Modern rheumatology, 28, 5, 838-844 |
Modern rheumatology, 28, 5, 838-844 |
Modern rheumatology, 28, 5, 838-844 |
2018/09 |
有 |
|
|
公開 |
| Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T |
Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T |
Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T |
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. |
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. |
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. |
Scientific reports, 8, 1, 10262 |
Scientific reports, 8, 1, 10262 |
Scientific reports, 8, 1, 10262 |
2018/07 |
有 |
|
|
公開 |
| Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T |
Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T |
Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T |
Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. |
Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. |
Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. |
Journal of gastroenterology, 53, 7, 845-853 |
Journal of gastroenterology, 53, 7, 845-853 |
Journal of gastroenterology, 53, 7, 845-853 |
2018/07 |
有 |
|
|
公開 |
| Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T |
Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T |
Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T |
Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. |
Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. |
Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. |
Modern rheumatology, 28, 4, 626-636 |
Modern rheumatology, 28, 4, 626-636 |
Modern rheumatology, 28, 4, 626-636 |
2018/07 |
有 |
|
|
公開 |
| Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T |
Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T |
Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T |
Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. |
Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. |
Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. |
Modern rheumatology, 28, 4, 724-729 |
Modern rheumatology, 28, 4, 724-729 |
Modern rheumatology, 28, 4, 724-729 |
2018/07 |
有 |
|
|
公開 |
| Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M |
Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M |
Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M |
Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. |
Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. |
Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 |
2018/06 |
有 |
|
|
公開 |
| Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T |
Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T |
Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T |
Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. |
Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. |
Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. |
Arthritis research & therapy, 20, 1, 13 |
Arthritis research & therapy, 20, 1, 13 |
Arthritis research & therapy, 20, 1, 13 |
2018/01 |
有 |
|
|
公開 |
| Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T |
Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T |
Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T |
A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. |
A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. |
A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. |
Arthritis research & therapy, 19, 1, 197 |
Arthritis research & therapy, 19, 1, 197 |
Arthritis research & therapy, 19, 1, 197 |
2017/09 |
有 |
|
|
公開 |
| Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K |
Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K |
Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K |
Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. |
Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. |
Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. |
The Journal of rheumatology, 44, 9, 1384-1388 |
The Journal of rheumatology, 44, 9, 1384-1388 |
The Journal of rheumatology, 44, 9, 1384-1388 |
2017/09 |
有 |
|
|
公開 |
| Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T |
Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T |
Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T |
Clinical Images: Chronic Nonbacterial Osteomyelitis. |
Clinical Images: Chronic Nonbacterial Osteomyelitis. |
Clinical Images: Chronic Nonbacterial Osteomyelitis. |
Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 |
Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 |
Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 |
2017/08 |
有 |
|
|
公開 |
| Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C |
Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C |
Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C |
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.  |
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. |
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. |
Scientific reports, 7, 1, 6911 |
Scientific reports, 7, 1, 6911 |
Scientific reports, 7, 1, 6911 |
2017/07 |
有 |
|
|
公開 |
| Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K |
Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K |
Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K |
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. |
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. |
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. |
Rheumatology (Oxford, England), 56, 7, 1217-1226 |
Rheumatology (Oxford, England), 56, 7, 1217-1226 |
Rheumatology (Oxford, England), 56, 7, 1217-1226 |
2017/07 |
有 |
|
|
公開 |
| Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y |
Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y |
Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y |
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. |
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. |
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. |
Annals of the rheumatic diseases, 76, 6, 1150-1158 |
Annals of the rheumatic diseases, 76, 6, 1150-1158 |
Annals of the rheumatic diseases, 76, 6, 1150-1158 |
2017/06 |
有 |
|
|
公開 |
| Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T |
Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T |
Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T |
Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. |
Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. |
Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. |
International journal of rheumatic diseases, 20, 6, 731-736 |
International journal of rheumatic diseases, 20, 6, 731-736 |
International journal of rheumatic diseases, 20, 6, 731-736 |
2017/06 |
有 |
|
|
公開 |
| Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T |
Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T |
Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T |
Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. |
Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. |
Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. |
Modern rheumatology, 27, 3, 448-456 |
Modern rheumatology, 27, 3, 448-456 |
Modern rheumatology, 27, 3, 448-456 |
2017/05 |
有 |
|
|
公開 |
| Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T |
Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T |
Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T |
Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. |
Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. |
Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. |
Journal of autoimmunity, 77, 116-122 |
Journal of autoimmunity, 77, 116-122 |
Journal of autoimmunity, 77, 116-122 |
2017/02 |
有 |
|
|
公開 |
| Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T |
Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T |
Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T |
Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. |
Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. |
Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. |
Modern rheumatology, 27, 1, 155-161 |
Modern rheumatology, 27, 1, 155-161 |
Modern rheumatology, 27, 1, 155-161 |
2017/01 |
有 |
|
|
公開 |
| Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. |
Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. |
Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. |
PloS one, 12, 9, e0184738 |
PloS one, 12, 9, e0184738 |
PloS one, 12, 9, e0184738 |
2017 |
有 |
|
|
公開 |
| Kitagori K, Yoshifuji H |
Kitagori K, Yoshifuji H |
Kitagori K, Yoshifuji H |
Osteopontin in systemic lupus erythematosus. |
Osteopontin in systemic lupus erythematosus. |
Osteopontin in systemic lupus erythematosus. |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 |
2017 |
有 |
|
|
公開 |
| Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A |
High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. |
High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. |
High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. |
Pathology research international, 2017, 9312142 |
Pathology research international, 2017, 9312142 |
Pathology research international, 2017, 9312142 |
2017 |
有 |
|
|
公開 |
| Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F |
Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. |
Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. |
Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. |
Rheumatology (Oxford, England), 55, 9, 1686-1692 |
Rheumatology (Oxford, England), 55, 9, 1686-1692 |
Rheumatology (Oxford, England), 55, 9, 1686-1692 |
2016/09 |
有 |
|
|
公開 |
| Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T |
Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T |
Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T |
Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. |
Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. |
Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. |
PloS one, 11, 12, e0167141 |
PloS one, 11, 12, e0167141 |
PloS one, 11, 12, e0167141 |
2016 |
有 |
|
|
公開 |
| Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T |
Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T |
Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T |
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. |
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. |
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. |
Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 |
Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 |
Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 |
2016 |
有 |
|
|
公開 |
| Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T |
Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T |
Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T |
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. |
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. |
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. |
Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 |
Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 |
Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 |
2016 |
有 |
|
|
公開 |
| Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T |
Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T |
Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T |
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. |
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. |
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 |
2016 |
有 |
|
|
公開 |
| Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. |
Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. |
Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. |
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
Arthritis care & research, 67, 10, 1354-1362 |
Arthritis care & research, 67, 10, 1354-1362 |
Arthritis care & research, 67, 10, 1354-1362 |
2015/10 |
有 |
|
|
公開 |
| Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T |
Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T |
Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T |
Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. |
Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. |
Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. |
BMC musculoskeletal disorders, 16, 129 |
BMC musculoskeletal disorders, 16, 129 |
BMC musculoskeletal disorders, 16, 129 |
2015/05 |
有 |
|
|
公開 |
| Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F |
Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F |
Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F |
Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. |
Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. |
Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. |
Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 |
Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 |
Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 |
2015/05 |
有 |
|
|
公開 |
| Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T |
Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T |
Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T |
Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. |
Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. |
Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. |
PloS one, 10, 12, e0144952 |
PloS one, 10, 12, e0144952 |
PloS one, 10, 12, e0144952 |
2015 |
有 |
|
|
公開 |
| Yoshifuji H |
Yoshifuji H |
Yoshifuji H |
Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. |
Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. |
Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. |
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 |
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 |
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 |
2015 |
有 |
|
|
公開 |
| Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J |
Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J |
Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J |
Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. |
Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. |
Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. |
Immunity, inflammation and disease, 2, 1, 35-43 |
Immunity, inflammation and disease, 2, 1, 35-43 |
Immunity, inflammation and disease, 2, 1, 35-43 |
2014/06 |
有 |
|
|
公開 |
| Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T |
Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T |
Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T |
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. |
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. |
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. |
Modern rheumatology, 24, 3, 464-470 |
Modern rheumatology, 24, 3, 464-470 |
Modern rheumatology, 24, 3, 464-470 |
2014/05 |
有 |
|
|
公開 |
| C. Terao; H. Yoshifuji; T. Mimori |
C. Terao; H. Yoshifuji; T. Mimori |
C. Terao; H. Yoshifuji; T. Mimori |
Recent advances in Takayasu arteritis |
Recent advances in Takayasu arteritis |
Recent advances in Takayasu arteritis |
International Journal of Rheumatic Diseases, 17, 3, 238-247 |
International Journal of Rheumatic Diseases, 17, 3, 238-247 |
International Journal of Rheumatic Diseases, 17, 3, 238-247 |
2014/03 |
有 |
英語 |
|
公開 |
| N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori |
N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori |
N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori |
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders |
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders |
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders |
Journal of Rheumatology, 41, 2, 293-299 |
Journal of Rheumatology, 41, 2, 293-299 |
Journal of Rheumatology, 41, 2, 293-299 |
2014/02 |
有 |
英語 |
|
公開 |
| K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda |
K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda |
K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda |
Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases |
Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases |
Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases |
Journal of Human Genetics, 59, 2, 107-109 |
Journal of Human Genetics, 59, 2, 107-109 |
Journal of Human Genetics, 59, 2, 107-109 |
2014/02 |
有 |
英語 |
|
公開 |
| Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T |
Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. |
Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. |
Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. |
Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 |
Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 |
Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 |
2014 |
有 |
|
|
公開 |
| Terao C, Yoshifuji H, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Mimori T, Matsuda F |
Terao C, Yoshifuji H, Mimori T, Matsuda F |
[Susceptibility HLA alleles and amino acids to Takayasu arteritis]. |
[Susceptibility HLA alleles and amino acids to Takayasu arteritis]. |
[Susceptibility HLA alleles and amino acids to Takayasu arteritis]. |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 |
2014 |
有 |
|
|
公開 |
| Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T |
Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T |
Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T |
Inverse association between air pressure and rheumatoid arthritis synovitis. |
Inverse association between air pressure and rheumatoid arthritis synovitis. |
Inverse association between air pressure and rheumatoid arthritis synovitis. |
PloS one, 9, 1, e85376 |
PloS one, 9, 1, e85376 |
PloS one, 9, 1, e85376 |
2014 |
有 |
|
|
公開 |
| Yoshifuji H, Kinoshita H |
Yoshifuji H, Kinoshita H |
Yoshifuji H, Kinoshita H |
[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. |
[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. |
[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 |
2014 |
有 |
|
|
公開 |
| Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori |
Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori |
Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori |
A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis |
A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis |
A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis |
Modern Rheumatology, 23, 6, 1221-1225 |
Modern Rheumatology, 23, 6, 1221-1225 |
Modern Rheumatology, 23, 6, 1221-1225 |
2013/11 |
有 |
英語 |
|
公開 |
| C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda |
C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda |
C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda |
Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. |
Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. |
Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. |
Rheumatology (Oxford, England), 52, 10, 1769-1774 |
Rheumatology (Oxford, England), 52, 10, 1769-1774 |
Rheumatology (Oxford, England), 52, 10, 1769-1774 |
2013/10 |
有 |
英語 |
|
公開 |
| C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda |
C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda |
C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda |
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population |
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population |
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population |
American Journal of Human Genetics, 93, 2, 289-297 |
American Journal of Human Genetics, 93, 2, 289-297 |
American Journal of Human Genetics, 93, 2, 289-297 |
2013/08/08 |
有 |
英語 |
|
公開 |
| H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori |
H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori |
H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori |
Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature |
Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature |
Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature |
Journal of Dermatology, 40, 8, 641-648 |
Journal of Dermatology, 40, 8, 641-648 |
Journal of Dermatology, 40, 8, 641-648 |
2013/08 |
有 |
英語 |
|
公開 |
| C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori |
C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori |
C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori |
Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database |
Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database |
Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database |
PLoS ONE, 8, 3, e59341 |
PLoS ONE, 8, 3, e59341 |
PLoS ONE, 8, 3, e59341 |
2013 |
有 |
英語 |
|
公開 |
| M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori |
M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori |
M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori |
Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis |
Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis |
Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis |
PLoS ONE, 8, 5, e62231 |
PLoS ONE, 8, 5, e62231 |
PLoS ONE, 8, 5, e62231 |
2013 |
有 |
英語 |
|
公開 |
| Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
2013 |
有 |
|
|
公開 |
| Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori |
Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori |
Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori |
NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA |
NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA |
NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA |
Modern Rheumatology, 22, 5, 685-694 |
Modern Rheumatology, 22, 5, 685-694 |
Modern Rheumatology, 22, 5, 685-694 |
2012/09 |
有 |
英語 |
|
公開 |
| K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori |
K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori |
K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori |
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance |
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance |
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance |
Arthritis Research and Therapy, 14, 2, R86 |
Arthritis Research and Therapy, 14, 2, R86 |
Arthritis Research and Therapy, 14, 2, R86 |
2012/04 |
有 |
英語 |
|
公開 |
| K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori |
K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori |
K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori |
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 |
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 |
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 |
FEBS Letters, 586, 4, 319-324 |
FEBS Letters, 586, 4, 319-324 |
FEBS Letters, 586, 4, 319-324 |
2012/02 |
有 |
英語 |
|
公開 |
| M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori |
M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori |
M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori |
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells |
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells |
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells |
Clinical and Experimental Immunology, 170, 1, 94-100 |
Clinical and Experimental Immunology, 170, 1, 94-100 |
Clinical and Experimental Immunology, 170, 1, 94-100 |
2012 |
有 |
英語 |
|
公開 |
| J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond |
J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond |
J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond |
Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation |
Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation |
Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation |
Journal of Immunology, 186, 9, 5304-5312 |
Journal of Immunology, 186, 9, 5304-5312 |
Journal of Immunology, 186, 9, 5304-5312 |
2011/05 |
有 |
英語 |
|
公開 |
| M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals |
Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals |
Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals |
PLoS ONE, 6, 10, e27020 |
PLoS ONE, 6, 10, e27020 |
PLoS ONE, 6, 10, e27020 |
2011 |
有 |
英語 |
|
公開 |
| N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori |
N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori |
N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori |
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study |
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study |
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study |
Arthritis Research and Therapy, 13, 6, R213 |
Arthritis Research and Therapy, 13, 6, R213 |
Arthritis Research and Therapy, 13, 6, R213 |
2011 |
有 |
英語 |
|
公開 |
| Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori |
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis |
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis |
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis |
Arthritis and Rheumatism, 60, 8, 2294-2303 |
Arthritis and Rheumatism, 60, 8, 2294-2303 |
Arthritis and Rheumatism, 60, 8, 2294-2303 |
2009/08 |
有 |
英語 |
|
公開 |
| R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori |
R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori |
R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori |
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody |
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody |
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody |
Rheumatology, 49, 3, 433-440 |
Rheumatology, 49, 3, 433-440 |
Rheumatology, 49, 3, 433-440 |
2009 |
有 |
英語 |
|
公開 |
| T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji |
T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji |
T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji |
Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance |
Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance |
Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance |
Current Opinion in Rheumatology, 19, 6, 523-529 |
Current Opinion in Rheumatology, 19, 6, 523-529 |
Current Opinion in Rheumatology, 19, 6, 523-529 |
2007/11 |
有 |
英語 |
|
公開 |
| K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori |
K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori |
K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori |
Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus |
Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus |
Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus |
Modern Rheumatology, 17, 2, 167-170 |
Modern Rheumatology, 17, 2, 167-170 |
Modern Rheumatology, 17, 2, 167-170 |
2007 |
有 |
英語 |
|
公開 |
| Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori |
Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori |
Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori |
Severe subcutaneous generalized edema in a patient with dermatomyositis |
Severe subcutaneous generalized edema in a patient with dermatomyositis |
Severe subcutaneous generalized edema in a patient with dermatomyositis |
Modern Rheumatology, 17, 2, 171-173 |
Modern Rheumatology, 17, 2, 171-173 |
Modern Rheumatology, 17, 2, 171-173 |
2007 |
有 |
英語 |
|
公開 |
| S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka |
S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka |
S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka |
Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial |
Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial |
Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial |
Modern Rheumatology, 17, 6, 464-469 |
Modern Rheumatology, 17, 6, 464-469 |
Modern Rheumatology, 17, 6, 464-469 |
2007 |
有 |
英語 |
|
公開 |
| H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori |
H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori |
H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori |
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies |
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies |
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies |
Autoimmunity, 39, 3, 233-241 |
Autoimmunity, 39, 3, 233-241 |
Autoimmunity, 39, 3, 233-241 |
2006/05 |
有 |
英語 |
|
公開 |
| H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori |
H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori |
H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori |
Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro |
Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro |
Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro |
International Immunology, 17, 10, 1327-1336 |
International Immunology, 17, 10, 1327-1336 |
International Immunology, 17, 10, 1327-1336 |
2005 |
有 |
英語 |
|
公開 |
| M. Hashimoto; H. Yoshifuji; T. Mimori |
M. Hashimoto; H. Yoshifuji; T. Mimori |
Hashimoto M, Yoshifuji H, Mimori T |
A case of dermatomyositis associated with different types of cancers at intervals of six years |
A case of dermatomyositis associated with different types of cancers at intervals of six years |
[A case of dermatomyositis associated with different types of cancers at intervals of six years]. |
Nihon Rinsho Men\\'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 |
Nihon Rinsho Men\\'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 |
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 |
2004/12 |
有 |
日本語 |
|
公開 |
| D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki |
D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki |
D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki |
Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis |
Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis |
Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis |
Arthritis and Rheumatism, 50, 2, 660-668 |
Arthritis and Rheumatism, 50, 2, 660-668 |
Arthritis and Rheumatism, 50, 2, 660-668 |
2004/02 |
有 |
英語 |
|
公開 |
HOME
教育研究活動データベースについて
利用方法について
